VR Logo

Simulations Plus Inc. (SLP) download report


Healthcare | Health Services

Simulations Plus Inc. (SLP) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide.

IPO Date: 18-Jun-1997

Co-Founder & Chairman: Mr. Walter S. Woltosz M.A.S., M.S.

Chief Exec. Officer: Mr. Shawn M. O'Connor

Listing: NASDAQ: SLP

Country: United States

Headquarters: Lancaster, CA

Website: https://www.simulations-plus.com

Key Facts

Market cap: $1,306.41 Mln

Revenue (TTM): $52.01 Mln

Earnings (TTM): $11.83 Mln

Cash: $122.47 Mln

Total Debt: $1.53 Mln

Insider's Holding: 21.21%

Liquidity: Low

52 Week range: $35.18 - 67.59

Shares outstanding: 20,235,600

10 Years Aggregate:

  • CFO: $89.26 Mln
  • EBITDA: $98.20 Mln
  • Net Profit: $64.00 Mln

Stock Performance

Time Period Simulations Plus (SLP) S&P BSE Healthcare* S&P Small-Cap 600*
YTD38.18-11.26-12.41
1 month20.795.347.33
3 months52.571.471.57
1 Year35.41-11.82-9.48
3 Years18.0422.769.22
5 Years35.2310.867.59
10 Years31.6812.2710.53
As on 09-Aug-2022 *As on 08-Aug-2022
Year Simulations Plus (SLP) S&P Small-Cap 600 S&P BSE Healthcare
2021-34.2325.2720.87
2020147.409.5761.45
201946.0820.86-3.55
201823.46-9.70-5.89
201766.8411.730.49
2016-2.6224.74-12.88
201548.35-3.3615.06